HUTCHMED (LON:HCM) Stock Passes Above 50 Day Moving Average – Here’s Why
by Jessica Moore · The Cerbat GemHUTCHMED (China) Limited (LON:HCM – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 214.52 and traded as high as GBX 229. HUTCHMED shares last traded at GBX 220, with a volume of 82,607 shares.
HUTCHMED Stock Performance
The company has a market capitalization of £1.89 billion, a P/E ratio of 4.15 and a beta of 0.45. The company has a debt-to-equity ratio of 7.91, a current ratio of 4.96 and a quick ratio of 2.97. The company has a fifty day moving average price of GBX 214.60 and a two-hundred day moving average price of GBX 218.03.
HUTCHMED Company Profile
We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S.
We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China.
HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange’s AIM market (Nasdaq/AIM:HCM; HKEX:13).